Group 1: Macro Insights - Trump has approved a military strike plan against Iran but has not yet issued a final order, pending Iran's response regarding its nuclear program [1] - The Federal Reserve has maintained the federal funds rate target range at 4.25% to 4.50% for the fourth consecutive time, with expectations of two rate cuts by the end of the year [2] - The Central Financial Committee has issued opinions to support Shanghai in becoming a high-quality development demonstration zone for listed companies [3] Group 2: Market Developments - The China Securities Regulatory Commission (CSRC) has established a growth tier on the Sci-Tech Innovation Board, aimed at unprofitable tech companies with significant breakthroughs and commercial potential [4] - Gilead's HIV prevention drug has received FDA approval, showing a 96% reduction in infection risk, indicating sustained growth in the innovative drug sector [8] - The domestic smart glasses market is expected to double in shipments this year, with companies like Rokid and Meta launching new products [9] - The PCB sector has seen the emergence of a new billion-dollar company, driven by AI technology and high-value product demand [10]
A股盘前播报 | 特朗普批准对伊朗打击计划 美联储连续第四次维持利率不变
智通财经网·2025-06-19 00:37